Clinical Research Directory
Browse clinical research sites, groups, and studies.
China Atrial Fibrillation With Complex Metabolic Disorder Cohort Study (CAME Cohort)
Sponsor: Xiangya Hospital of Central South University
Summary
The number of atrial fibrillation (AF) patients in China is approximately 32.76 million, with a prevalence rate of 2.3%. AF is associated with severe outcomes such as stroke and heart failure. Metabolic disorders (e.g., obesity, diabetes mellitus, dyslipidemia) are closely linked to the onset and prognosis of AF. However, the epidemiological characteristics and disease burden of AF combined with metabolic disorders in China remain unclear. Additionally, the impact of complex multi-dimensional metabolic disorders on AF prognosis requires further investigation, and current clinical guidelines lack targeted management recommendations for this population.
Official title: China Atrial Fibrillation With Complex Metabolic Disorders Cohort Study (CAME Cohort)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
3459
Start Date
2026-02-01
Completion Date
2036-06-01
Last Updated
2025-12-30
Healthy Volunteers
No